1. Home
  2. RDY vs PPC Comparison

RDY vs PPC Comparison

Compare RDY & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • PPC
  • Stock Information
  • Founded
  • RDY 1984
  • PPC 1946
  • Country
  • RDY India
  • PPC United States
  • Employees
  • RDY N/A
  • PPC N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • PPC Meat/Poultry/Fish
  • Sector
  • RDY Health Care
  • PPC Consumer Staples
  • Exchange
  • RDY Nasdaq
  • PPC Nasdaq
  • Market Cap
  • RDY 11.8B
  • PPC 12.5B
  • IPO Year
  • RDY N/A
  • PPC 1987
  • Fundamental
  • Price
  • RDY $14.12
  • PPC $44.64
  • Analyst Decision
  • RDY Strong Buy
  • PPC Hold
  • Analyst Count
  • RDY 2
  • PPC 5
  • Target Price
  • RDY $16.95
  • PPC $49.00
  • AVG Volume (30 Days)
  • RDY 962.0K
  • PPC 1.2M
  • Earning Date
  • RDY 07-23-2025
  • PPC 10-29-2025
  • Dividend Yield
  • RDY 0.51%
  • PPC 18.78%
  • EPS Growth
  • RDY 2.20
  • PPC 62.69
  • EPS
  • RDY 0.79
  • PPC 5.19
  • Revenue
  • RDY $3,897,394,052.00
  • PPC $18,177,417,000.00
  • Revenue This Year
  • RDY $7.33
  • PPC $3.72
  • Revenue Next Year
  • RDY $1.96
  • PPC $0.72
  • P/E Ratio
  • RDY $17.94
  • PPC $8.62
  • Revenue Growth
  • RDY 15.86
  • PPC 2.06
  • 52 Week Low
  • RDY $12.26
  • PPC $40.09
  • 52 Week High
  • RDY $16.41
  • PPC $57.16
  • Technical
  • Relative Strength Index (RSI)
  • RDY 45.65
  • PPC 37.20
  • Support Level
  • RDY $14.08
  • PPC $43.54
  • Resistance Level
  • RDY $14.32
  • PPC $47.67
  • Average True Range (ATR)
  • RDY 0.18
  • PPC 1.16
  • MACD
  • RDY 0.03
  • PPC -0.48
  • Stochastic Oscillator
  • RDY 10.38
  • PPC 16.79

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About PPC Pilgrim's Pride Corporation

Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS' offer undervalued Pilgrim's Pride.

Share on Social Networks: